These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33058492)

  • 1. Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient.
    Lo Barco T; Osanni E; Bordugo A; Rodella G; Iascone M; Tenconi R; Barone R; Dalla Bernardina B; Cantalupo G
    Am J Med Genet A; 2021 Jan; 185(1):219-222. PubMed ID: 33058492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies.
    Morava E; Tiemes V; Thiel C; Seta N; de Lonlay P; de Klerk H; Mulder M; Rubio-Gozalbo E; Visser G; van Hasselt P; Horovitz DDG; de Souza CFM; Schwartz IVD; Green A; Al-Owain M; Uziel G; Sigaudy S; Chabrol B; van Spronsen FJ; Steinert M; Komini E; Wurm D; Bevot A; Ayadi A; Huijben K; Dercksen M; Witters P; Jaeken J; Matthijs G; Lefeber DJ; Wevers RA
    J Inherit Metab Dis; 2016 Sep; 39(5):713-723. PubMed ID: 27287710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset epileptic and developmental encephalopathy and MOGS variants: a new diagnosis in the whole exome sequencing (WES) ERA : Report of a new patient and review of the literature.
    Teutonico F; Volpe C; Proto A; Costi I; Cavallari U; Doneda P; Iascone M; Sturiale L; Barone R; Martinelli S; Vignoli A
    Neurogenetics; 2024 Jul; 25(3):281-286. PubMed ID: 38498292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
    Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
    Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC35A2-CDG: novel variants with two ends of the spectrum.
    Kasapkara ÇS; Ceylan AC; Özyürek H; Karakaya Molla G; Civelek Ürey B; Kıreker Köylü O; Küçükçongar Yavaş A; Sönmez FM
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1185-1189. PubMed ID: 34161696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic spasms in congenital disorders of glycosylation.
    Pereira AG; Bahi-Buisson N; Barnerias C; Boddaert N; Nabbout R; de Lonlay P; Kaminska A; Eisermann M
    Epileptic Disord; 2017 Mar; 19(1):15-23. PubMed ID: 28300031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelines.
    Shah R; Eklund EA; Radenkovic S; Sadek M; Shammas I; Verberkmoes S; Ng BG; Freeze HH; Edmondson AC; He M; Kozicz T; Altassan R; Morava E
    Mol Genet Metab; 2024 Jun; 142(2):108472. PubMed ID: 38703411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual Presentation of PMM2-Congenital Disorder of Glycosylation With Isolated Strokelike Episodes in a Young Girl.
    Farmania R; Jain P; Sharma S; Aneja S
    J Child Neurol; 2019 Jun; 34(7):410-414. PubMed ID: 30857461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygous variants in MOGS inducing congenital disorders of glycosylation (CDG) IIb.
    Li M; Xu Y; Wang Y; Yang XA; Jin D
    J Hum Genet; 2019 Mar; 64(3):265-268. PubMed ID: 30587846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperkinetic movement disorders in congenital disorders of glycosylation.
    Mostile G; Barone R; Nicoletti A; Rizzo R; Martinelli D; Sturiale L; Fiumara A; Jankovic J; Zappia M
    Eur J Neurol; 2019 Sep; 26(9):1226-1234. PubMed ID: 31132195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital disorders of glycosylation.
    Jaeken J
    Handb Clin Neurol; 2013; 113():1737-43. PubMed ID: 23622397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy.
    Kimizu T; Takahashi Y; Oboshi T; Horino A; Koike T; Yoshitomi S; Mori T; Yamaguchi T; Ikeda H; Okamoto N; Nakashima M; Saitsu H; Kato M; Matsumoto N; Imai K
    Brain Dev; 2017 Mar; 39(3):256-260. PubMed ID: 27743886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype.
    Elsharkawi I; Wongkittichote P; Daniel EJP; Starosta RT; Ueda K; Ng BG; Freeze HH; He M; Shinawi M
    J Inherit Metab Dis; 2023 Jan; 46(1):92-100. PubMed ID: 36214423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOGS-CDG: Quantitative analysis of the diagnostic Glc
    Post MA; de Wit I; Zijlstra FSM; Engelke UFH; van Rooij A; Christodoulou J; Tan TY; Le Fevre A; Jin D; Yaplito-Lee J; Lee BH; Low KJ; Mallick AA; Õunap K; Pitt J; Reardon W; Vals MA; Wortmann SB; Wessels HJCT; Bärenfänger M; van Karnebeek CDM; Lefeber DJ
    J Inherit Metab Dis; 2023 Mar; 46(2):313-325. PubMed ID: 36651519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.
    Vals MA; Ashikov A; Ilves P; Loorits D; Zeng Q; Barone R; Huijben K; Sykut-Cegielska J; Diogo L; Elias AF; Greenwood RS; Grunewald S; van Hasselt PM; van de Kamp JM; Mancini G; Okninska A; Pajusalu S; Rudd PM; Rustad CF; Salvarinova R; de Vries BBA; Wolf NI; ; Ng BG; Freeze HH; Lefeber DJ; Õunap K
    J Inherit Metab Dis; 2019 May; 42(3):553-564. PubMed ID: 30746764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALG11-CDG syndrome: Expanding the phenotype.
    Haanpää MK; Ng BG; Gallant NM; Singh KE; Brown C; Kimonis V; Freeze HH; Muller EA
    Am J Med Genet A; 2019 Mar; 179(3):498-502. PubMed ID: 30676690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligosaccharyltransferase complex-congenital disorders of glycosylation: A novel congenital disorder of glycosylation.
    Bryant EM; Millichap JJ; Spinelli E; Calhoun JD; Miller C; Giannelli J; Wolak J; Sanders V; Carvill GL; Charrow J
    Am J Med Genet A; 2020 Jun; 182(6):1460-1465. PubMed ID: 32267060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
    Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDG-Id in two siblings with partially different phenotypes.
    Kranz C; Sun L; Eklund EA; Krasnewich D; Casey JR; Freeze HH
    Am J Med Genet A; 2007 Jul; 143A(13):1414-20. PubMed ID: 17551933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings.
    Riess S; Reddihough DS; Howell KB; Dagia C; Jaeken J; Matthijs G; Yaplito-Lee J
    Mol Genet Metab; 2013; 110(1-2):170-5. PubMed ID: 23791010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.